Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00042003
Status:
COMPLETED
Last Update Posted:
2020-01-18
First Post:
2002-07-19
Brief Title:
Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate Gleevec
Sponsor:
Astex Pharmaceuticals Inc
Organization:
Astex Pharmaceuticals Inc
Organization Data
Organization:
Astex Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
DAC-012
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Astex Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Eisai Inc | INDUSTRY |